BJ
Blue Jay Capital Management, LLC
高频交易型行业集中型趋势追踪型
申报总市值
US$1.5亿
申报季度: 2017-06-30 · 持股只数: 20
BLUE JAY CAPITAL MANAGEMENT, LLC在最新一期 13F 报告中披露了 20 项持股，申报期为 2017-06-30，总持股市值约为 US$1.5亿，季度换手率为 95.2%。
机构性格雪花图
- 集中度
- 20.78
- 持仓稳定性
- 95.25
- 动能／逆势
- 100
- 行业集中度
- 100
- 多样化
- 40
- 仓位均衡度
- 97.97
近期动向
加仓 CLVSEUR
-33.9% -US$27.2万
加仓 INCY
+3.4% -US$24.2万
加仓 N96617118
+4.7% -US$72.0万
加仓 BMRN
-10.0% -US$63.9万
加仓 EW
-25.3% -US$51.2万
加仓 PRAH
-23.9% -US$113.9万
持仓地图
新建仓加仓不变减仓
前十大持股占比
本季完整持股清单
| # | 代码 | 标的名称 | 资产子类别 | 占比 | 占比变动 | 持仓量变化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | T8S | Tesaro INC | 股票-其他 | 6.43% | +0.03% | -20.27% | |
| 2 | CLVSEUR | Clovis Oncology INC | 股票-其他 | 6.32% | +1.62% | -33.93% | |
| 3 | INCY | Incyte CORP | 股票-医疗保健 | 6.18% | +1.60% | +3.41% | |
| 4 | IRWD | Ironwood Pharmaceuticals INC | 股票-其他 | 6.05% | +0.39% | -30.37% | |
| 5 | ✓ | Wright Medical Group NV | 股票-其他 | 6.00% | +1.32% | +4.66% | |
| 6 | BMRN | Biomarin Pharmaceutical INC | 股票-医疗保健 | 5.84% | +1.31% | -10.04% | |
| 7 | PRAH | Pra Health Sciences INC | 股票-其他 | 5.45% | +0.96% | -23.89% | |
| 8 | EW | Edwards Lifesciences CORP | 股票-医疗保健 | 5.42% | +1.26% | -25.26% | |
| 9 | ABMDEUR | Abiomed INC | 股票-其他 | 5.41% | +0.79% | -26.15% | |
| 10 | NVROEUR | Nevro CORP | 股票-其他 | 5.33% | +0.72% | +5.00% | |
| 11 | QGEN | Qiagen N.V. | 股票-医疗保健 | 4.98% | +4.98% | NEW | |
| 12 | SNN | Smith & Nephew PLC -spon Adr | 股票-其他 | 4.75% | +4.75% | NEW | |
| 13 | PTLAEUR | Portola Pharmaceuticals INC | 股票-其他 | 4.59% | +4.59% | NEW | |
| 14 | NBIX | Neurocrine Biosciences INC | 股票-医疗保健 | 4.55% | +4.55% | NEW | |
| 15 | BKD | Brookdale Senior Living INC | 股票-其他 | 4.51% | +4.51% | NEW | |
| 16 | ICLR | ICON Public Limited Company | 股票-医疗保健 | 4.22% | +4.22% | NEW | |
| 17 | VRTX | Vertex Pharmaceuticals INC | 股票-医疗保健 | 4.06% | -0.25% | -42.36% | |
| 18 | ALGN | Align Technology INC | 股票-医疗保健 | 3.47% | +3.47% | NEW | |
| 19 | ILMN | Illumina INC | 股票-医疗保健 | 3.25% | +3.25% | NEW | |
| 20 | ISRG | Intuitive Surgical INC | 股票-医疗保健 | 3.19% | +3.19% | NEW |
申报总市值趋势
行业配置
历年行业分布趋势
季度历史总览
| 季度 | 持股只数 | 总市值 | 稳定性 | 主要持股 |
|---|---|---|---|---|
| 2017-06-30 | 20 | US$1.5亿 | 95 | |
| 2017-03-31 | 21 | US$2.0亿 | 100 | |
| 2016-12-31 | 15 | US$1.7亿 | 100 | |
| 2016-09-30 | 17 | US$1.8亿 | 100 | |
| 2016-06-30 | 14 | US$1.5亿 | 100 | |
| 2016-03-31 | 16 | US$1.6亿 | 100 | |
| 2015-12-31 | 23 | US$3.0亿 | 100 | |
| 2015-09-30 | 18 | US$2.5亿 | 100 | |
| 2015-06-30 | 28 | US$3.7亿 | 97 | |
| 2015-03-31 | 21 | US$2.9亿 | 100 | |
| 2014-12-31 | 23 | US$2.2亿 | 0 |
本季持股变动
Blue Jay Capital Management, LLC 在 2017-06-30 最显著的持仓异动： 清仓: Biogen INC (BIIB); 清仓: Globus Medical INC - A (GMED); 清仓: Qiagen N.V. (QGEN); 清仓: Bristol-myers Squibb Co (BMY); 清仓: Cr Bard INC (BCRUSD).
| # | 代码 | 标的名称 | 占比变动 | 持仓量变化 | 异动类型 |
|---|---|---|---|---|---|
| 1 | CLVSEUR | Clovis Oncology INC | +1.6% | -33.93% | 减仓 |
| 2 | INCY | Incyte CORP | +1.6% | +3.41% | 加仓 |
| 3 | ✓ | Wright Medical Group NV | +1.3% | +4.66% | 加仓 |
| 4 | BMRN | Biomarin Pharmaceutical INC | +1.3% | -10.04% | 减仓 |
| 5 | EW | Edwards Lifesciences CORP | +1.3% | -25.26% | 减仓 |
| 6 | PRAH | Pra Health Sciences INC | +1% | -23.89% | 减仓 |
| 7 | ABMDEUR | Abiomed INC | +0.8% | -26.15% | 减仓 |
| 8 | NVROEUR | Nevro CORP | +0.7% | +5.00% | 加仓 |
| 9 | IRWD | Ironwood Pharmaceuticals INC | +0.4% | -30.37% | 减仓 |
| 10 | T8S | Tesaro INC | 0% | -20.27% | 减仓 |
| 11 | VRTX | Vertex Pharmaceuticals INC | -0.3% | -42.36% | 减仓 |
| 12 | BIIB | Biogen INC | — | EXIT | 清仓 |
| 13 | GMED | Globus Medical INC - A | — | EXIT | 清仓 |
| 14 | QGEN | Qiagen N.V. | — | EXIT | 清仓 |
| 15 | BMY | Bristol-myers Squibb Co | — | EXIT | 清仓 |
| 16 | BCRUSD | Cr Bard INC | — | EXIT | 清仓 |
| 17 | NUVAGBP | Nuvasive INC | — | EXIT | 清仓 |
| 18 | CELG | Celgene CORP | — | EXIT | 清仓 |
| 19 | MDRX | Veradigm INC | — | EXIT | 清仓 |
| 20 | QGEN | Qiagen N.V. | — | NEW | 新建仓 |
| 21 | AKRXEUR | Akorn INC | — | EXIT | 清仓 |
| 22 | DERMEUR | Dermira INC | — | EXIT | 清仓 |
| 23 | SNN | Smith & Nephew PLC -spon Adr | — | NEW | 新建仓 |
| 24 | PTLAEUR | Portola Pharmaceuticals INC | — | NEW | 新建仓 |
| 25 | NBIX | Neurocrine Biosciences INC | — | NEW | 新建仓 |
| 26 | BKD | Brookdale Senior Living INC | — | NEW | 新建仓 |
| 27 | ICLR | ICON Public Limited Company | — | NEW | 新建仓 |
| 28 | ALGN | Align Technology INC | — | NEW | 新建仓 |
| 29 | ILMN | Illumina INC | — | NEW | 新建仓 |
| 30 | ISRG | Intuitive Surgical INC | — | NEW | 新建仓 |
FAQ
Blue Jay Capital Management, LLC 是什么机构？属于哪种投资人类型？
Blue Jay Capital Management, LLC 是一家投资管理机构，每季依规定向 SEC 申报 Form 13F，披露其在美国上市股票的持仓信息。根据最新一期申报（2017-06-30），该机构追踪的股票投资组合估值约为 US$1.5亿，分布在 20 个已申报仓位之中。
Blue Jay Capital Management, LLC 目前前几大持股有哪些？
根据最新 13F 申报，Blue Jay Capital Management, LLC 按市值排列的前几大持股为：
1. Tesaro INC (T8S) — US$943.9万 (6.4%)
2. Clovis Oncology INC (CLVSEUR) — US$927.9万 (6.3%)
3. Incyte CORP (INCY) — US$907.2万 (6.2%)
4. Ironwood Pharmaceuticals INC (IRWD) — US$887.4万 (6.0%)
5. Wright Medical Group NV — US$880.8万 (6.0%)
Blue Jay Capital Management, LLC 在最新一期 13F 申报中做了哪些操作？
在最新申报季度中，Blue Jay Capital Management, LLC 共进行了 30 项显著调整：新建仓 9 个仓位、加仓 3 个既有持股、减仓 8 个仓位，并完全清仓 10 个持股。 其中幅度最大的异动：清仓: Biogen INC (BIIB); 清仓: Globus Medical INC - A (GMED); 清仓: Qiagen N.V. (QGEN); 清仓: Bristol-myers Squibb Co (BMY); 清仓: Cr Bard INC (BCRUSD)
Blue Jay Capital Management, LLC 主要集中投资哪些行业板块？
根据目前已申报的股票投资组合，Blue Jay Capital Management, LLC 的主要板块分布如下：
• Health Care: 100.0%